Arcoma AB (OSTO:ARCOMA) Other Current Liabilities: kr6.7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ARCOMA Arcoma AB OSTO:ARCOMA
75 GF Score
Price kr8.44
GF Value kr7.88
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Arcoma AB Other Current Liabilities?

Arcoma AB OSTO:ARCOMA 75 Other Current Liabilities is kr6.7 Mil as of Mar. 2026. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.88 (Fairly Valued). The stock has 2 warning signs investors should review.

Arcoma AB's other current liabilities for the quarter that ended in Mar. 2026 was kr6.7 Mil.

Arcoma AB's quarterly other current liabilities increased from Sep. 2025 (kr6.2 Mil) to Dec. 2025 (kr6.4 Mil) and increased from Dec. 2025 (kr6.4 Mil) to Mar. 2026 (kr6.7 Mil).

Arcoma AB's annual other current liabilities declined from Dec. 2023 (kr7.8 Mil) to Dec. 2024 (kr6.9 Mil) and declined from Dec. 2024 (kr6.9 Mil) to Dec. 2025 (kr6.4 Mil).

Arcoma AB Other Current Liabilities Related Terms

Arcoma AB Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Arcoma AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcoma AB Other Current Liabilities Chart

Arcoma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.97 6.04 7.82 6.92 6.40

Arcoma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.70 7.15 6.22 6.40 6.74
OSTO:ARCOMA
75GF Score
Arcoma AB OSTO:ARCOMA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcoma AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of kr6.7 Mil mean?
Arcoma AB (OSTO:ARCOMA) has a Other Current Liabilities of kr6.7 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Arcoma AB.
Is Arcoma AB's Other Current Liabilities too high?
Arcoma AB's current Other Current Liabilities is kr6.7 Mil. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's Other Current Liabilities compare to ABT and SYK?
Arcoma AB's Other Current Liabilities of kr6.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Arcoma AB. Arcoma AB's current Other Current Liabilities is kr6.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Fairly Valued. The stock's GF Value™ is kr7.88, compared to a current price of kr8.44 — trading 7.1% above its estimated fair value. The current Other Current Liabilities is kr6.7 Mil. Arcoma AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current Other Current Liabilities is kr6.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?

Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued. The current stock price of kr8.44 is trading 7.1% above its estimated GF Value™ of kr7.88. GuruFocus considers Arcoma AB to be Fairly Valued.

Key valuation signals for OSTO:ARCOMA:

  • Other Current Liabilities: kr6.7 Mil
  • GF Value™: kr7.88 vs. price of kr8.44 (7.1% above fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arcoma AB Business Description

Address Annavagen 1, Vaxjo, SWE, SE-352 46
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score

Get the complete analysis for OSTO:ARCOMA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.44
Price
kr7.88
GF Value